Evidence map›Paper›PMID 27706134›Full record

ArticleNature2016

De novo assembly and phasing of a Korean human genome.

Jeong-Sun Seo, Arang Rhie, Junsoo Kim, Sangjin Lee, Min-Hwan Sohn, Chang-Uk Kim, Alex Hastie, Han Cao, Ji-Young Yun, Jihye Kim and 11 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed
32.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 359 citations in OpenAlex.

  1. Long-read sequencing for neurological disorders: opportunities, challenges, and future directions.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Methods for Chromosome-Scale Haplotype Reconstruction.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Jeong-Sun SeoGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Arang RhieGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Junsoo KimGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Sangjin LeeGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Min-Hwan SohnGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Chang-Uk KimGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Alex HastieBioNano Genomics, San Diego, California 92121, USA.
Han CaoBioNano Genomics, San Diego, California 92121, USA.
Ji-Young YunGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Jihye KimGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Junho KukGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Gun Hwa ParkGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Juhyeok KimGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Hanna RyuBioinformatics Institute, Macrogen Inc., Seoul 153-023, South Korea.
Jongbum KimBioinformatics Institute, Macrogen Inc., Seoul 153-023, South Korea.
Mira RohBioinformatics Institute, Macrogen Inc., Seoul 153-023, South Korea.
Jeonghun BaekBioinformatics Institute, Macrogen Inc., Seoul 153-023, South Korea.
Michael W HunkapillerPacific Biosciences of California, Inc., Menlo Park, California 94025, USA.
Jonas KorlachPacific Biosciences of California, Inc., Menlo Park, California 94025, USA.
Jong-Yeon ShinGenomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul 110-799, South Korea.
Changhoon KimBioinformatics Institute, Macrogen Inc., Seoul 153-023, South Korea.
Seoul National University Hospital · KRMacrogen (South Korea) · KRSeoul National University · KRBioNano Genomics (United States) · USPacific Biosciences (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in genome assembly and phasing provide an opportunity to investigate the diploid architecture of the human genome and reveal the full range of structural variation across population groups. Here we report the de novo assembly and haplotype phasing of the Korean individual AK1 (ref. 1) using single-molecule real-time sequencing, next-generation mapping, microfluidics-based linked reads, and bacterial artificial chromosome (BAC) sequencing approaches. Single-molecule sequencing coupled with next-generation mapping generated a highly contiguous assembly, with a contig N50 size of 17.9 Mb and a scaffold N50 size of 44.8 Mb, resolving 8 chromosomal arms into single scaffolds. The de novo assembly, along with local assemblies and spanning long reads, closes 105 and extends into 72 out of 190 euchromatic gaps in the reference genome, adding 1.03 Mb of previously intractable sequence. High concordance between the assembly and paired-end sequences from 62,758 BAC clones provides strong support for the robustness of the assembly. We identify 18,210 structural variants by direct comparison of the assembly with the human reference, identifying thousands of breakpoints that, to our knowledge, have not been reported before. Many of the insertions are reflected in the transcriptome and are shared across the Asian population. We performed haplotype phasing of the assembly with short reads, long reads and linked reads from whole-genome sequencing and with short reads from 31,719 BAC clones, thereby achieving phased blocks with an N50 size of 11.6 Mb. Haplotigs assembled from single-molecule real-time reads assigned to haplotypes on phased blocks covered 89% of genes. The haplotigs accurately characterized the hypervariable major histocompatability complex region as well as demonstrating allele configuration in clinically relevant genes such as CYP2D6. This work presents the most contiguous diploid human genome assembly so far, with extensive investigation of unreported and Asian-specific structural variants, and high-quality haplotyping of clinically relevant alleles for precision medicine.

Indexed as

Contig MappingGenomicsSequence Analysis, DNAAllelesAsian PeopleChromosomes, Artificial, BacterialCytochrome P-450 CYP2D6DiploidyGenetic VariationGenome, HumanHaplotypesHistocompatibility Antigens Class IIHumansPrecision MedicineReference StandardsRepublic of KoreaCytochrome P-450 CYP2D6Histocompatibility Antigens Class II

Identifiers

PMID27706134
OpenAlexW2527708324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.